维普中文期刊产品整合服务
9篇 您的检索式:作者名="Varkaris"
    题名 作者 年代 出处 被引量
1Combined inhibition of IGF-IR/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways显示文摘Dayyani F Parikh NU Varkaris AS 0,,12:1
2The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials 显示文摘Varkaris A Corn PG Gaur S 2011Expert Opin Investig Drugs2011,20,12:1
3The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials显示文摘Andreas Varkaris Paul G Corn Sanchaika Gaur Farshid Dayyani Christopher J Logothetis Gary E Gallick 2011Expert Opinion on Investigational Drugs2011,,12:1
4The role of HGF/c- Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials显示文摘VARKARIS A CORN PG GAUR S 2011Expert Opin Investig Drugs2011,20,12:1
5Ligand-independent activation of MET through IGF-1/IGF-1R signaling 显示文摘Varkaris A Gaur S Parikh NU 2013Int J Cancer2013,133,7:1
6Src signaling pathways in prostate cancer显示文摘Varkaris A Katsiampoura AD Araujo JC 2014Cancer Meta Rev2014,33,23:1
7Targeted therapies in multiple myeloma显示文摘Kastritis E Charidimou A Varkaris A 2009Target Oncol2009,4,1:1
8Targeted therapies in multipie myeloma显示文摘Kastritis E Charidimou A Varkaris A 2009Target Oneol2009,4,1:1
9Ligand-independent activation of MET through IGF-1/IGF-1R signaling 显示文摘Varkaris A Gaur S Parikh NU 2013Int J Cancer2013,133,7:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费